ReWalk Robotics Ltd. (LFWD)
NASDAQ: LFWD · IEX Real-Time Price · USD
3.800
-0.130 (-3.31%)
At close: Jul 19, 2024, 4:00 PM
3.990
+0.190 (5.00%)
Pre-market: Jul 22, 2024, 7:08 AM EDT
ReWalk Robotics Revenue
ReWalk Robotics had revenue of $17.91M in the twelve months ending March 31, 2024, with 205.32% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.28M with 329.51% year-over-year growth. In the year 2023, ReWalk Robotics had annual revenue of $13.85M with 151.39% growth.
Revenue (ttm)
$17.91M
Revenue Growth
+205.32%
P/S Ratio
1.83
Revenue / Employee
$165,806
Employees
108
Market Cap
32.69M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 13.85M | 8.34M | 151.39% |
Dec 31, 2022 | 5.51M | -455.00K | -7.63% |
Dec 31, 2021 | 5.97M | 1.57M | 35.81% |
Dec 31, 2020 | 4.39M | -480.00K | -9.85% |
Dec 31, 2019 | 4.87M | -1.67M | -25.55% |
Dec 31, 2018 | 6.55M | -1.21M | -15.58% |
Dec 31, 2017 | 7.75M | 1.88M | 32.10% |
Dec 31, 2016 | 5.87M | 2.12M | 56.67% |
Dec 31, 2015 | 3.75M | -205.00K | -5.19% |
Dec 31, 2014 | 3.95M | 2.36M | 148.80% |
Dec 31, 2013 | 1.59M | 616.00K | 63.37% |
Dec 31, 2012 | 972.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nutex Health | 258.77M |
Cutera | 196.64M |
IRIDEX | 49.92M |
Retractable Technologies | 40.20M |
ImmuCell | 21.28M |
Longeveron | 978.00K |
Orgenesis | 529.00K |
LFWD News
- 19 days ago - Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors - GlobeNewsWire
- 25 days ago - Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO - GlobeNewsWire
- 6 weeks ago - Lifeward to Present at Sidoti Virtual Investor Conference on June 12 - GlobeNewsWire
- 2 months ago - Lifeward Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Lifeward to Report First Quarter Financial Results on May 15, 2024 - GlobeNewsWire
- 3 months ago - Lifeward Announces the Appointment of Mike Swinford to its Board of Directors - GlobeNewsWire
- 3 months ago - Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton - GlobeNewsWire
- 3 months ago - Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate - GlobeNewsWire